KIM GEMBECKI: Open Payments
NPI 1154581577 · VALHALLA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,128 in 39 payments from 9 companies in 2025. Trend: 2023 $417 · 2024 $1,631 · 2025 $1,128
Food & beverage: $1,128
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $408 |
| Lilly USA, LLC | 10 | $235 |
| Novo Nordisk Inc | 5 | $209 |
| Abbott Laboratories | 1 | $92 |
| PFIZER INC. | 4 | $85 |
| GlaxoSmithKline, LLC. | 1 | $31 |
| Exact Sciences Corporation | 1 | $26 |
| SHIELD THERAPEUTICS INC | 1 | $22 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
Products named: MOUNJARO, VRAYLAR, UBRELVY, Wegovy, FREESTYLE LIBRE, PREVNAR 20, AREXVY, Cologuard Collection Kit.
Industry payments across NY — which companies pay providers there.
